Application of Peak Nasal Inspiratory Flow reference values in the treatment of allergic rhinitis

Rhinology
|June 17, 2014
PubMed

Insights

Peak Nasal Inspiratory Flow (PNIF) curves effectively monitor children with allergic rhinitis. Intranasal corticosteroid treatment significantly improved PNIF percentages compared to placebo, showing PNIF

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Clinical Research

Background:

  • Allergic rhinitis (AR) is a common condition in children, impacting their quality of life.
  • Effective monitoring of AR treatment is crucial for optimal patient outcomes.
  • Peak Nasal Inspiratory Flow (PNIF) is a physiological measure that can reflect nasal obstruction.

Purpose of the Study:

  • To evaluate the clinical utility of Peak Nasal Inspiratory Flow (PNIF) curves for monitoring treatment response in children with allergic rhinitis.
  • To compare the effectiveness of intranasal corticosteroid spray versus saline solution in improving PNIF and clinical symptoms.

Main Methods:

  • A prospective study involving 40 children diagnosed with allergic rhinitis.
  • Participants were randomized to receive either intranasal corticosteroid spray or physiological saline solution for 10 weeks.
  • Clinical scores and PNIF percentages (relative to reference curves) were assessed throughout the study period, with a washout at week 8.

Main Results:

  • A statistically significant influence of treatment group, time, and their interaction was observed on PNIF percentages.
  • Children treated with intranasal corticosteroids demonstrated significantly higher mean PNIF percentages compared to the placebo group.
  • Clinical score improvements were also significantly greater in the corticosteroid treatment group.

Conclusions:

  • Peak Nasal Inspiratory Flow (PNIF) curves are applicable and effective in the follow-up of children undergoing treatment for allergic rhinitis.
  • Intranasal corticosteroid therapy leads to significant improvements in nasal airflow, as measured by PNIF, in pediatric patients with AR.
Abstract

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
922
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Epistaxis01:30

Epistaxis

Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
849